Aspira Women's Health Overview
- Year Founded
-
1993
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
AWHL
- Investments
-
4
- Share Price
-
$0.19
- (As of Thursday Closing)
Aspira Women's Health General Information
Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its main products include OvaWatch, Ova1Plus, Ova1, and Overa, which are used to assess ovarian cancer risk in women with adnexal masses. The company is also developing EndoCheck for endometriosis. The company views its operations and manages its business in a single operating segment, which is the discovery, development, and commercialization of noninvasive diagnostic tests.
Contact Information
Website
www.aspirawh.comCorporate Office
- 12117 Bee Caves Road
- Building III, Suite 100
- Austin, TX 78738
- United States
Corporate Office
- 12117 Bee Caves Road
- Building III, Suite 100
- Austin, TX 78738
- United States
Aspira Women's Health Timeline
Aspira Women's Health Stock Performance
As of 12-Nov-2026, Aspira Women's Health’s stock price is $0.19. Its current market cap is $8.84M with 46.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.19 | $0.16 | $0.13 - $0.68 | $8.84M | 46.6M | 20.8K | -$0.24 |
Aspira Women's Health Financials Summary
As of 30-Jun-2026, Aspira Women's Health has a trailing 12-month revenue of $8.55M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 21,881 | 26,166 | 11,759 | 39,411 |
| Revenue | 8,546 | 9,216 | 9,182 | 9,154 |
| EBITDA | (9,365) | (12,627) | (12,969) | 182,262 |
| Net Income | (10,005) | (12,780) | (13,094) | (16,690) |
| Total Assets | 4,435 | 5,456 | 5,491 | 6,262 |
| Total Debt | 3,105 | 2,980 | 3,376 | 2,852 |
Aspira Women's Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aspira Women's Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Aspira Women's Health Comparisons
Industry
Financing
Details
Aspira Women's Health Competitors (20)
One of Aspira Women's Health’s 20 competitors is Myriad Genetics, a Corporation company based in Salt Lake City, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Myriad Genetics | Corporation | Salt Lake City, UT | ||||
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| Natera | Formerly VC-backed | Austin, TX | ||||
| Becton, Dickinson and Company | Corporation | Franklin Lakes, NJ |
Aspira Women's Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aspira Women's Health Patents
Aspira Women's Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023406952-A1 | Compositions for endometriosis assessment having improved specificity | Pending | 02-Dec-2022 | ||
| EP-4627348-A1 | Compositions for endometriosis assessment having improved specificity | Pending | 02-Dec-2022 | ||
| US-20250290933-A1 | Compositions for endometriosis assessment having improved specificity | Pending | 02-Dec-2022 | ||
| WO-2024119119-A1 | Compositions for endometriosis assessment having improved specificity | Inactive | 02-Dec-2022 | ||
| EP-4500184-A1 | Methods for characterizing an adnexal mass | Inactive | 29-Mar-2022 | G01N33/57545 |
Aspira Women's Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aspira Women's Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aspira Women's Health Investments & Acquisitions (4)
Aspira Women's Health’s most recent deal was a Seed Round with ACTO for . The deal was made on 05-Jan-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ACTO | 05-Jan-2018 | Seed Round | Business/Productivity Software | ||
| Correlogic Systems | 19-Dec-2011 | Merger/Acquisition | Diagnostic Equipment | ||
| Correlogic Systems (Ovarian Cancer Diagnostics Business) | 19-Dec-2011 | Merger/Acquisition | Buildings and Property | ||
| Perquest | 27-Jul-2007 | Later Stage VC | Consumer Finance |
Aspira Women's Health ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Aspira Women's Health Exits (1)
Aspira Women's Health’s most recent exit was on 27-Jul-2007 from Perquest. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Perquest | 27-Jul-2007 | Completed |
|
Aspira Women's Health FAQs
-
When was Aspira Women's Health founded?
Aspira Women's Health was founded in 1993.
-
Where is Aspira Women's Health headquartered?
Aspira Women's Health is headquartered in Austin, TX.
-
What is the size of Aspira Women's Health?
Aspira Women's Health has 38 total employees.
-
What industry is Aspira Women's Health in?
Aspira Women's Health’s primary industry is Diagnostic Equipment.
-
Is Aspira Women's Health a private or public company?
Aspira Women's Health is a Public company.
-
What is Aspira Women's Health’s stock symbol?
The ticker symbol for Aspira Women's Health is AWHL.
-
What is the current stock price of Aspira Women's Health?
As of 12-Nov-2026 the stock price of Aspira Women's Health is $0.19.
-
What is the current market cap of Aspira Women's Health?
The current market capitalization of Aspira Women's Health is $8.84M.
-
What is Aspira Women's Health’s current revenue?
The trailing twelve month revenue for Aspira Women's Health is $8.55M.
-
Who are Aspira Women's Health’s competitors?
Myriad Genetics, CirculoGene, Decipher Urologic Cancers, Natera, and Becton, Dickinson and Company are some of the 20 competitors of Aspira Women's Health.
-
What is Aspira Women's Health’s annual earnings per share (EPS)?
Aspira Women's Health’s EPS for 12 months was -$0.24.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
